Action and Signaling of Lysophosphatidylethanolamine in MDA-MB-231 Breast Cancer Cells
Previously, we reported that lysophosphatidylethanolamine (LPE), a lyso-type metabolite of phosphatidylethanolamine, can increase intracellular Ca2+ ([Ca2+]i) via type 1 lysophosphatidic acid (LPA) receptor (LPA1) and CD97, an adhesion G-protein-coupled receptor (GPCR), in MDA-MB-231 breast cancer c...
Main Authors: | , , |
---|---|
Format: | Online |
Language: | English |
Published: |
The Korean Society of Applied Pharmacology
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975480/ |